Ruber Juan Bravo University Hospital joins the RESILIENCE project
Ruber Juan Bravo University Hospital in Madrid has joined the RESILIENCE project in August with the aim of collaborating with us to reduce the prevalence of chronic heart failure in cancer survivors. Dr. Arancha Alonso, hematologist at the Hospital and principal investigator of this center in RESILIENCE believes that “the participation in this trial is […]
Evolution of RESILIENCE
Newsletter N.10, June 2024 This Project has received funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 945118 Evolution of RESILIENCE We continue working for the growth of the project because for us every patient counts ❤ Interviews Dr. Maria Gomes Da Silva https://youtu.be/3G_E0IoXhFg?si=fVCxWzNVJ9bIfvUA Check the interview with Maria […]
Save the date! Open activities RESILIENCE in September and November
In the framework of the European Researchers’ Night and the Science and Innovation Week to be celebrated in Madrid on September and November, our team RESILIENCE has planned two activities open to public of all ages upon registration. There will be two workshops and roundtables under the title “RESILIENCE: Survive cancer with a strong heart”, […]
Patient encounter: stories of resilience and improvement
Since we started the RESILIENCE project, we have held regular encounters with our patients, and family members who wish to attend, along with members of our team. We believe these gatherings are a fruitful experience in which they have the chance of sharing their needs with us so we may get to know aspects to […]
Doctor Alberto López answers your questions about cardiovascular health
Due to the commemoration of the European Day for the Prevention of Cardiovascular Risk on March 14th we have launched a campaign on our Instagram to collect your questions and concerns about this topic. Doctor Alberto López, member of our RESILIENCE team, have answered them. Dr. López is an expert in Hematology at the Hospital […]
Amsterdam UMC Hospital joins RESILIENCE
It is a great satisfaction for us to announce the incorporation of the Amsterdam UMC Hospital to the RESILIENCE project on November 8th. Amsterdam UMC is one of the largest academic hospitals in the Netherlands and consists of 2 centers: The Amsterdam UMC located at the AMC (Academic Medical Center) and the Amsterdam UMC, located […]
Puerta de Hierro University Hospital joins RESILIENCE
On October 23rd, Puerta de Hierro Majadahonda University Hospital joined the RESILIENCE project, so hopefully it will begin to incorporate patients into the trial in the coming days. This hospital was created in 1964 and, since then, it has fulfilled a triple function: care, teaching and research. Currently, as a public institution dependent on the […]
Heart failure may no longer be a death sentence for cancer survivors
Cancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without cancer. The ground-breaking RESILIENCE project aims to prevent heart failure in patients who need anthracyclines to treat their cancer. International experts and patients from the project gathered on October 19th at the European Heart House, […]
Science and Innovation Week
On Thursday, November 16th at 19:00 hours we will organize the “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” within the activities held in Madrid on the occasion of the Science and Innovation Week. The “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” will consist of a free activity, for the public of all ages, […]
Building a career as a cardiovascular investigator
During the Global Cardio Oncology Summit 2023, that took place in Madrid last September 27th, we had the opportunity of listening Dr. Borja Ibáñez, coordinator of RESILIENCE project and Scientific Director of CNIC, discussing with Dr. Bonnie Ky, Director of the Penn Center for Quantitative Echocardiography and Thalheimer Center for Cardio-Oncology and editor-in-chief of JACC: […]
